MSD‑CARE

MSD‑CARE (2024–2025) addresses musculoskeletal disorders (MSDs) among formal and informal caregivers in North‑West Europe, who frequently experience musculoskeletal‑related pain and absenteeism  Despite cost‑effective solutions (like exoskeletons), uptake remains low due to soft barriers—lack of awareness, socio‑behavioral resistance, and limited decision‑support tools.

Through focus groups, workshops (e.g., exoskeleton trials at Galway, Enschede and Göttingen), and transnational analysis, MSD‑CARE co‑develops strategies with caregivers, employers, policymakers, and researchers. It aims to equip caregivers with decision tools and recommendations, fostering long‑term adoption of MSD‑prevention technologies and improved occupational health.